Transcriptomics

Dataset Information

0

IFN-λ treatment accelerates SARS-CoV-2 clearance despite age-related delays in the induction of T cell immunity


ABSTRACT: Interferons (IFNs) induced early after SARS-CoV-2 infection are crucial for shaping immunity and preventing severe COVID-19. We previously demonstrated that injection of pegylated interferon-lambda1 (PEG-IFN-λ) accelerated viral clearance in COVID-19 patients. To determine if the viral decline was mediated by enhanced immunity, we assessed in vivo responses to PEG-IFN-λ by single cell RNA sequencing and measured SARS-CoV-2-specific T cell and antibody responses between placebo and PEG-IFN-λ-treated patients. PEG-IFN-λ treatment induced interferon stimulated genes in peripheral immune cells expressing IFNLR1, including plasmacytoid dendritic cells and B cells. PEG-IFN-λ did not affect SARS-CoV-2-specific antibody levels or the magnitude of virus-specific T cells. However, we identified delayed T cell responses in older adults, suggesting that PEG-IFN-λ can overcome delays in adaptive immunity to accelerate viral clearance in high-risk patients. Altogether, PEG-IFN-λ offers an early COVID-19 treatment option for outpatients to boost innate antiviral defenses without dampening peripheral adaptive immunity.

ORGANISM(S): Homo sapiens

PROVIDER: GSE215814 | GEO | 2022/10/14

REPOSITORIES: GEO

Dataset's files

Source:
Action DRS
Other
Items per page:
1 - 1 of 1

Similar Datasets

2024-09-18 | GSE253635 | GEO
2024-09-05 | GSE274586 | GEO
2024-08-20 | GSE274686 | GEO
2021-03-20 | E-MTAB-10169 | biostudies-arrayexpress
2022-02-01 | E-MTAB-10129 | biostudies-arrayexpress
2021-01-01 | GSE156544 | GEO
2021-10-01 | GSE178967 | GEO
2022-02-22 | GSE196980 | GEO
2022-11-16 | GSE205429 | GEO
2023-09-06 | GSE237092 | GEO